Improving the Solubility and Oral Bioavailability of a Novel Aromatic Aldehyde Antisickling Agent (PP10) for the Treatment of Sickle Cell DiseaseTarek A. Ahmed, Martin K. Safo, Piyusha P. Pagare et al.|Pharmaceutics|2021Cited by 5
Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation PotentialAbdelsattar M. Omar, Martin K. Safo, Moustafa E. El‐Araby et al.|ChemMedChem|2025Cited by 1
A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease - <i>In Vivo</i> Efficacy of Ilx-002 in Humanized MiceOsheiza Abdulmalik, Andrew N. Fleischman, R. Clark Brown et al.|Blood|2024Cited by 0